Skip to main content
OpenTrials
Completed

NCT Number: NCT00940394

Effectiveness of Family Group Interventions for People With Schizophrenia

The mutual support group intervention would significantly improve the families' burden of care, functioning and social support, reduce the patients' severity of symptoms and re-hospitalizations, and reduce the demands for utilization of family services, when compared with the standard care group.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Li Ka Shing Specialty OPD, Shatin, NT, Hong Kong

Loading trial locations.

About this study

Family interventions in schizophrenia have shown positive effects on patients but little attention has been paid to their effects on family members, particularly those in non-Western countries. This multi-site randomized controlled trial evaluated the effectiveness of a bi-weekly, 12-session, family-led mutual support group for Chinese caregivers of schizophrenia sufferers over 36 months, compared with a family psychoeducation group program and standard psychiatric care. It was conducted with 114 families of outpatients with schizophrenia in Hong Kong of whom 38 were assigned randomly to a mutual support group, a psychoeducation group, or standard care. Families' psychosocial health status and patients' symptom severity and length of re-hospitalizations at recruitment, one-month, 18-month, and 36-month post-intervention were compared between groups.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • family caregivers lived with and cared for one family member diagnosed with schizophrenia according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV; American Psychiatric Association, 1994)
  • family caregivers were at least 18 years of age and could understand and read the Chinese (Mandarin) language; and
  • family caregivers were free from any mental illness themselves.

Exclusion criteria

  • the patients with schizophrenia suffered no co-morbidity due to other mental illness during recruitment to the study
  • family caregivers cared for more than one family member with mental or chronic physical illness; and/or
  • family caregivers had been the primary carers for less than three months

Treatment and study plan

mutual support group

Behavioral

bi-weekly, 12-session, family-led mutual support group

Other names: FMSG

Psychoeducation group

Behavioral

bi-weekly, 12-session, family psychoeducation group

Other names: FPGP

Standard care

Other

Routine mental health care services provided by the outpatient clinic and related agencies for families of people with schizophrenia

Other names: Usual psychiatric care

Primary outcomes

  1. length of re-hospitalizations

    Time frame: at recruitment, six-month, 18-month and 36-month post-intervention

Secondary outcomes

  1. families' perceived social support

    Time frame: at recruitment, six-month, 18-month and 36-month post-intervention

  2. patients' symptom severity

    Time frame: at recruitment, six-month, 18-month and 36-month post-intervention

Sponsors and collaborators

Lead sponsor

The Hong Kong Polytechnic University

Other

Registry information

Official study title

Evaluation of the Effects of Mutual Support and Psycho-educational Group Interventions for Family Caregivers of People With Schizophrenia

Acronym: MSG

Important dates

Study start
2007
Primary completion
2011
Study completion
2011
First posted
Jul 16, 2009
Registry last updated
Aug 21, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.